Skip to content
10-K

Annual Report

Advanced Biomed Inc ADVB

0001213900-25-097465

← back to feed
Filed
Oct 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Oct 8, 2025 21.64M sh
Shares Diluted FY 2025 · Jun 30, 2025 20.53M sh
Shares Diluted FY 2025 · Jun 30, 2024 20M sh
Capex FY 2025 · Jun 30, 2025 $31.65K
Capex FY 2025 · Jun 30, 2024 $74.11K
Operating Cash Flow FY 2025 · Jun 30, 2025 −$5.83M
Operating Cash Flow FY 2025 · Jun 30, 2024 −$2.13M
Cash And Equivalents FY 2025 · Jun 30, 2025 $2.9M
Cash And Equivalents FY 2025 · Jun 30, 2024 $2.61M
Cash And Equivalents FY 2025 · Jun 30, 2023 $2.62M
Stockholders Equity FY 2025 · Jun 30, 2025 $3.48M
Stockholders Equity FY 2025 · Jun 30, 2024 $1.66M
Stockholders Equity FY 2025 · Jun 30, 2023 $1.31M
Current Liabilities FY 2025 · Jun 30, 2025 $2.89M
Current Liabilities FY 2025 · Jun 30, 2024 $2.73M
Total Liabilities FY 2025 · Jun 30, 2025 $3.03M
Total Liabilities FY 2025 · Jun 30, 2024 $2.8M
Current Assets FY 2025 · Jun 30, 2025 $6.03M
Current Assets FY 2025 · Jun 30, 2024 $3.05M
Total Assets FY 2025 · Jun 30, 2025 $6.51M
Total Assets FY 2025 · Jun 30, 2024 $4.46M
Eps Diluted FY 2025 · Jun 30, 2025 −$0.16
Eps Diluted FY 2025 · Jun 30, 2024 −$0.14
Eps Basic FY 2025 · Jun 30, 2025 −$0.16
Eps Basic FY 2025 · Jun 30, 2024 −$0.14
Sga Expense FY 2025 · Jun 30, 2025 $2.11M
Sga Expense FY 2025 · Jun 30, 2024 $1.66M
Rd Expense FY 2025 · Jun 30, 2025 $909.77K
Rd Expense FY 2025 · Jun 30, 2024 $880.19K
Net Income FY 2025 · Jun 30, 2025 −$3.26M
Net Income FY 2025 · Jun 30, 2024 −$2.78M